GlaxoSmithKline Pharmaceuticals Limited

NSE:GLAXO.NS

2561.15 (INR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 492.6-18,568.232860.76-16,053738.8-16,541.197349.4-13,052.3556.9-28,308.7942,861.871-11,890.75,963-11,372.0374,051.892-6,969.51,461.1-10,618.261,048.115-9,689.61,188.8-11,477.911987.766-12,701.163
Short Term Investments 21,411.337,136.46417,926.5232,10616,477.533,082.39417,769.326,104.613,00156,617.58826,165.39523,781.46,399.422,744.0747,320.14513,9395,508.421,236.529,570.14519,379.28,500.822,955.82210,490.14525,402.326
Cash and Short Term Investments 21,903.918,568.23218,787.2816,05317,216.316,541.19718,118.713,052.313,557.928,308.79429,027.26611,890.712,362.411,372.03711,372.0376,969.56,969.510,618.2610,618.269,689.69,689.611,477.91111,477.91112,701.163
Net Receivables 2,683.603,499.13202,110.701,923.801,65602,05203,586.105,130.29605,301.702,238.75701,065.203,635.2560
Inventory 5,176.205,339.1205,374.404,599.706,460.905,346.95405,359.905,466.98105,005.304,830.32204,578.904,864.9350
Other Current Assets 3,063.40358.6540292.20300.40278040.3360501.9057.2290624.5061.4750796.7083.2470
Total Current Assets 30,143.518,568.23227,984.18616,05324,993.616,541.19724,942.613,052.321,953.728,308.79437,080.32311,890.721,810.311,372.03722,026.5436,969.517,90110,618.2617,748.8149,689.616,130.411,477.91120,061.34912,701.163
Non-Current Assets:
Property, Plant & Equipment, Net 2,976.403,122.56403,142.503,151.203,232.903,254.47203,323.503,541.24103,752.708,270.867014,163.4013,670.9680
Goodwill 000000-0.00800000000000000000
Intangible Assets 183.40235.5380288.50340.9080297.30344.9740386.80433.640451.80496.2510742.90655.40
Goodwill and Intangible Assets 183.40235.5380288.50340.90297.30344.9740386.80433.640451.80496.2510742.90655.40
Long Term Investments 118.5034.1890-16,348.80-17,648.20-12,883.60-26,2470-6,282.40-7,280.0450-5,466.303,704.2880-8,458.60-10,489.5780
Tax Assets 1,502.501,634.47901,476.801,335.501,199.401,131.48101,096.301,031.26101,084.601,104.8640363.10622.2150
Other Non-Current Assets 2,535.6-18,568.2322,726.576-16,05319,149.5-16,541.19721,143.8-13,052.316,353.2-28,308.79430,768.32-11,890.710,204.9-11,372.03711,380.968-6,969.59,658.1-10,618.2630.326-9,689.612,254.2-11,477.91114,592.755-12,701.163
Total Non-Current Assets 7,316.4-18,568.2327,753.346-16,0537,708.5-16,541.1978,323.2-13,052.38,199.2-28,308.7949,252.247-11,890.78,729.1-11,372.0379,107.065-6,969.59,480.9-10,618.2613,606.596-9,689.619,065-11,477.91119,051.76-12,701.163
Total Assets 37,459.9035,737.532032,702.1033,265.8030,152.9046,332.778030,539.4031,133.608027,381.9031,355.41035,195.4039,113.1090
Liabilities & Equity:
Current Liabilities:
Account Payables 6,304.606,248.64305,629.904,277.904,696.505,705.48704,925.604,644.703,880.803,575.85103,332.604,058.1480
Short Term Debt 106.10121.9590139.60120.80143.80124.530148.10143.7670160.70149.7880004.060
Tax Payables 5,390.902,985.78903,218.102,96202,988.602,962.03502,706.201,637.22601,694.801,613.76201,489.601,534.3280
Deferred Revenue 5,390.9075.50508,262.308,302.900043.47407,429.408,366.27606,504.806,346.93300010,330.340
Other Current Liabilities 6,330.308,803.3540586.3056208,112.2011,110.79702,320.501700559.1017004,819.20150.6470
Total Current Liabilities 18,131.9015,249.461014,618.1013,263.6012,952.5016,984.288014,823.6013,324.743011,105.4010,242.57208,151.8014,543.1950
Non-Current Liabilities:
Long Term Debt 0064.691074.2034.6088.6076.23501280202.4990279.20268.612043101.770
Deferred Revenue Non-Current 00-0.009000-181.961000-188.857000-155.708000000022.010
Deferred Tax Liabilities Non-Current 00171.357000181.961000188.857000155.70800000003,125.8320
Other Non-Current Liabilities 2,601.1-17,776.3972,475.63502,614.302,554.802,562.802,642.69702,633.802,615.56902,724.602,638.17703,156.1022.010
Total Non-Current Liabilities 2,601.1-17,776.3972,711.67402,688.502,589.402,651.402,718.93202,761.802,818.06803,003.802,906.78903,587.103,171.6220
Total Liabilities 20,733-17,776.39717,961.135017,306.6015,853015,603.9019,703.22017,585.4016,142.811014,109.2013,149.361011,738.9017,714.8170
Equity:
Preferred Stock 00000000000000000028.22100000
Common Stock 1,694.101,694.0601,694.101,694.101,694.101,694.0601,694.101,694.0601,694.101,694.0601,694.101,694.060
Retained Earnings 008,764.3520008,114.91400017,425.4250005,468.4110008,755.18100011,875.9060
Accumulated Other Comprehensive Income/Loss 017,776.3977,317.98515,395.513,701.417,412.737,449.70714,54912,854.926,629.5587,510.07312,95411,259.914,990.7971,694.0613,272.711,578.618,206.049-28.22123,456.521,762.421,398.292-1,154.16120,573.289
Other Total Stockholders Equity 15,032.800000154.07900000006,134.2660007,756.8080008,982.4870
Total Shareholders Equity 16,726.917,776.39717,776.39715,395.515,395.517,412.7317,412.814,54914,54926,629.55826,629.55812,95412,95414,990.79714,990.79713,272.713,272.718,206.04918,206.04923,456.523,456.521,398.29221,398.29220,573.289
Total Equity 16,726.917,776.39717,776.39715,395.515,395.517,412.7317,412.814,54914,54926,629.55826,629.55812,95412,95414,990.79714,990.79713,272.713,272.718,206.04918,206.04923,456.523,456.521,398.29221,398.29220,573.289
Total Liabilities & Shareholders Equity 37,459.917,776.39735,737.53215,395.532,702.117,412.7333,265.814,54930,152.926,629.55846,332.77812,95430,539.414,990.79731,133.60813,272.727,381.918,206.04931,355.4123,456.535,195.421,398.29239,113.10920,573.289